All PlansCoverageMedium impact
Newsletter Vol. 28, No.19
New Jersey Medicaid·NJ · Family Medicine, Internal Medicine, Endocrinology +1 more·Provider Notice
We identified it
Jun 20, 2026
Summary
This policy update establishes metformin as the first-line treatment for Type 2 diabetes. Without access to the full document content, specific billing and coverage changes cannot be determined, but this may affect diabetes-related coding and documentation requirements.
Action Required
Billing team should review the full policy document at https://www.njmmis.com/documentDownload.aspx?document=28-19.pdf to identify specific billing code changes, prior authorization requirements, and documentation updates for Type 2 diabetes treatment. Update billing protocols accordingly once full policy is reviewed.